BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sorrento Therapeutics, Inc. 



San Diego  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
Sorrento Therapeutics, Inc. Acquires South American Rights To Cynviloq 5/1/2015 11:41:38 AM
Sorrento Therapeutics, Inc. Announces The Appointments Of David H. Deming To The Board Of Directors And Mark W. Durand As Chief Financial Officer 5/1/2015 7:38:55 AM
Sorrento Therapeutics, Inc. Announces Three Preclinical Poster Presentations On Cynviloq, Its Novel Antibody Drug Conjugate Linker Technology And C-Met/EGFR Bispecific ADC At The 106th Annual Meeting Of The AACR 4/20/2015 1:25:27 PM
Sorrento Therapeutics, Inc. To Present At Jefferies and Co. 2015 Immuno-Oncology Summit 4/13/2015 8:03:45 AM
Sorrento Therapeutics, Inc. Announces Appointment Of George Ng As EVP & Chief Legal Officer 3/30/2015 12:14:55 PM
NantWorks And Sorrento Therapeutics, Inc. Announce Second Comprehensive Global Collaboration On Discovery And Development Of Novel Anti-Cancer Immunotherapies 3/16/2015 7:28:07 AM
Sorrento Therapeutics, Inc. To Present At Cowen and Company's 35th Annual Health Care Conference 2/23/2015 8:35:25 AM
Sorrento Therapeutics, Inc. To Present At The 17th Annual BIO CEO & Investor Conference 2/5/2015 12:23:40 PM
Sorrento Therapeutics, Inc. Announces Retention Of Glen Sato To Provide Strategic Support 2/2/2015 2:42:30 PM
Sorrento Therapeutics, Inc. Announces Completion Of Enrollment In The Cynviloq™ Registrational TRIBECA™ Study 1/28/2015 8:25:42 AM
123456789